Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    The News CartelThe News Cartel
    Subscribe
    • Home
    • Business
    • Lifestyle
    • Entertainment
    • Education
    • National
    • Health
    • Technology
    • Finance
    • World
    • News
      • Ahmadabad
      • Amreli
      • Anand
      • Aravalli
      • Banaskantha
      • Bharuch
      • Bhavnagar
      • Botad
      • Chhota Udepur
      • Dahod
      • Dangs
      • Devbhumi Dwarka
      • Gandhinagar
      • Gir Somnath
      • Jamnagar
      • Junagadh
      • Kachchh
      • Kheda
      • Mahesana
      • Mahisagar
      • Morbi
      • Narmada
      • Navsari
      • Panchmahal
      • Patan
      • Porbandar
      • Rajkot
      • Sabarkantha
      • Surat
      • Surendranagar
      • Tapi
      • Vadodara
      • Vapi
    The News CartelThe News Cartel
    Home»Business»Lord’s Mark Industries Promoter Proposes Reinvestment of Share-Sale Proceeds in Medical Device Unit
    Business

    Lord’s Mark Industries Promoter Proposes Reinvestment of Share-Sale Proceeds in Medical Device Unit

    Shruti JoshiBy Shruti JoshiSeptember 23, 2026No Comments1 Min Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email
    0 0
    Read Time:58 Second

    New Delhi [India], September 24: Lord’s Mark Industries Limited has informed the BSE that its promoter, Sachidanand Hariram Upadhyay, has proposed to reinvest the majority of the proceeds received from a recent sale of equity shares into the expansion of the company’s medical device unit.

    According to the company’s September 24, 2026 exchange filing under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, the disclosure follows an earlier intimation made to the stock exchange on September 21 regarding the promoter’s share sale.

    The promoter sold 1,03,56,983 equity shares of Lord’s Mark Industries, having a face value of ₹10 each, on September 18, 2026. The transaction was carried out through a block deal/open-market transaction on the BSE and generated aggregate net proceeds of ₹87.39 crore. The company said the proceeds were credited to the promoter’s bank account.

    In the latest filing, the promoter confirmed and proposed that the majority of the funds received from the share sale would be reinvested towards expanding the company’s medical device unit through what the filing described as a “viable and acceptable means.

    Share

    Facebook
    Twitter
    Pinterest
    LinkedIn

    About Post Author

    Shruti Joshi

    https://thenewscartel.com
    Happy
    Happy
    0 0 %
    Sad
    Sad
    0 0 %
    Excited
    Excited
    0 0 %
    Sleepy
    Sleepy
    0 0 %
    Angry
    Angry
    0 0 %
    Surprise
    Surprise
    0 0 %
    Business
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticlePC Jeweller Clears Over 99% of Bank Debt, Repays 13 of 14 Consortium Lenders
    Next Article A Dream Come True as Usha Mangeshkar Ji’s Historic Praise and Blessings Created a Golden Chapter in Kaleem Pasha’s Musical Journey
    Shruti Joshi
    • Website

    Related Posts

    Alteryx Brings Governed Business Logic to Enterprise AI at Gartner Data & Analytics Summit 2026

    September 24, 2026

    PC Jeweller Clears Over 99% of Bank Debt, Repays 13 of 14 Consortium Lenders

    September 23, 2026

    Techmagnate Study Finds AI Platforms Drop 39% of Cited Brands Every Week, Signals Shift in How AI Visibility Should Be Measured

    September 23, 2026

    Average Rating

    5 Star
    0%
    4 Star
    0%
    3 Star
    0%
    2 Star
    0%
    1 Star
    0%
    (Add your review)
    © 2026 ThemeSphere. Designed by ThemeSphere.

    Type above and press Enter to search. Press Esc to cancel.